Pfizer will request the authorization of the vaccine from the third week of November
Pfizer’s late-stage coronavirus vaccine trial is near complete. The countdown to the arrival of the…
biotech
Singapore startup Breathonix develops 60-second COVID-19 breathalyzer test
Breathonix develops non-invasive breath tests for disease detection. Singapore’s Breathonix has said a clinical trial…
Moderna begins the procedures to market its Covid vaccine in Europe
Moderna prepares for the “commercial launch” of its vaccine. Modern biotechnology begins the procedures to…
Grifols begins clinical trials of its treatment for Covid-19 in patients infected with the virus
Grifols starts the trial to test its immunoglobulin in patients with Covid-19. Grifols has announced…
Foghorn blows its klaxon, gunning for a $100M IPO hot on the heels of its Merck deal
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells…
Sanofi buys Principia Biopharma for 3.11 billion euros
Merger between Sanofi and Principia Biopharma. The French pharmaceutical Sanofi has reached a “definitive agreement”…
FDA spurns CytoDyn’s HIV drug because of missing info
CytoDyn rejected by the FDA. The FDA rejected CytoDyn’s application for its lead program, an…
Insect genetically modified
Genetically modified mosquitoes for the field. A British biotech company has approval to release genetically…
Moderna Labs, first vaccine against COVID-19
Moderna lab, the small biotechnology that can save the world from COVID-19. Moderna is using…